ClinicalTrials.gg
Not yet recruitingNCT07943793RETROGRADEUpdated Nov 17, 2026

Ultrasound-Guided Tenolysis of the Finger Flexor Tendons

An observational study in Flexor Tendon Injury, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
189
Ages
18 Years and older
Sex
All
01

Study summary

Ultrasound-guided tenolysis allows faster return to activities compared to published data on open surgery. Patients with stenosing tenosynovitis of the 2nd, 3rd, 4th, and 5th fingers with surgical indication are enrolled. Our primary objective is the EVALUATION OF RECOVERY TIMES FOLLOWING ULTRASOUND-GUIDED TENOLYSIS, assessed through clinical evaluation of wound healing and full first closure at 7 days post-procedure. As a secondary objective, we aim to perform pre-operative ultrasound assessment of A1 pulley thickness to establish a possible correlation between pulley thickness and post-operative outcome, along with evaluation of return to daily activities using validated scoring tools (Quick DASH and SANE score). Pain perception will be assessed using the VAS scale, and any complications arising from this technique will be recorded and compared with those reported in the literature for open surgery.

Read the detailed description

Ultrasound-guided tenolysis allows faster return to activities compared to published data on open surgery. Patients with stenosing tenosynovitis of the 2nd, 3rd, 4th, and 5th fingers with surgical indication are enrolled. Our primary objective is the EVALUATION OF RECOVERY TIMES FOLLOWING ULTRASOUND-GUIDED TENOLYSIS, assessed through clinical evaluation of wound healing and full first closure at 7 days post-procedure. As a secondary objective, we aim to perform pre-operative ultrasound assessment of A1 pulley thickness to establish a possible correlation between pulley thickness and post-operative outcome, along with evaluation of return to daily activities using validated scoring tools (Quick DASH and SANE score). Pain perception will be assessed using the VAS scale, and any complications arising from this technique will be recorded and compared with those reported in the literature for open surgery.

  • Inclusion criteria:** Adult patients with stenosing tenosynovitis involving the 2nd, 3rd, 4th, and 5th fingers. Signed informed consent.
  • Exclusion criteria:** Patients with trigger thumb (1st finger). Patients with abundant flexor tenosynovitis detected on pre-operative ultrasound. Presence of other local pathological conditions in which simple tenolysis alone is insufficient. Pregnant or breastfeeding patients, or those presenting systemic clinical contraindications to surgery.

The study involves patient recruitment during the specialist visit, at which the patient's clinical characteristics are assessed for compliance with the inclusion criteria. The patient follows the standard pre-operative waiting and assessment process established by the protocols of Istituto Clinico San Siro. Patients undergo ultrasound examination performed by the first operator to evaluate A1 pulley thickness, degree of stenosis, and any associated pathological conditions in the pre-operative setting. This assessment aims to verify the correct surgical indication and, consequently, the patient's potential inclusion in the clinical study.

Under local anaesthesia, ultrasound-guided retrograde tenolysis is performed using a retrograde scalpel. A clinical follow-up is conducted at approximately one week, including assessment and completion of functional tests in standard use and approved by the scientific community. Patients are contacted by telephone at approximately one month post-procedure for final re-evaluation and confirmation of the findings observed at the first clinical check-up.

The study involves the enrollment of 189 patients, both prospective and retrospective.

02

Conditions studied

  • Flexor Tendon Injury

Browse trials for

03

In context

Tendon Injuries

101 studies on the registry are indexed under Tendon Injuries; 28 are open to participants now.

This study's planned enrollment of 189 is above the median of 50 across 29 observational studies indexed under Tendon Injuries.

Browse Tendon Injuries studies →

Lead sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio is the lead sponsor of 161 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

**Patients with stenosing tenosynovitis of the 2nd, 3rd, 4th, and 5th fingers with surgical indication.**

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients with stenosing tenosynovitis involving the 2nd, 3rd, 4th, and 5th fingers
  • Signed form

Exclusion criteria

Exclusion Criteria:

  • Patients with trigger thumb (1st finger)
  • Patients with abundant flexor tenosynovitis detected on pre-operative ultrasound
  • Presence of other local pathological conditions in which simple tenolysis alone is insufficient
  • Pregnant or breastfeeding patients
  • systemic clinical to surgery.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
189 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. evaluation of recovery times following ultrasound guided tenolysis

    Our primary objective is the EVALUATION OF RECOVERY TIMES FOLLOWING ULTRASOUND-GUIDED TENOLYSIS, assessed through clinical evaluation of wound healing and full fist closure at 7 days post-procedure.

    Time frame: 7 days

Secondary outcomes

  1. Pre operative evaluation of the A1 pulley thickness and its correlation with the evaluation of the return to daily activities using Quick Dash Score (0-100).

    Time frame: 30 days after surgery

  2. Pre operative evaluation of the A1 pulley thickness and its correlation with the evaluation of the return to daily activities using Sane Score (0%-100%).

    Time frame: 30 days after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Not yet decided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jun 2028, 19 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2026
First posted
Nov 17, 2026
StartEst.
Oct 20, 2026
Primary completionEst.
Jun 9, 2028
CompletionEst.
Jun 9, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943793
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Jun 9, 2028 (estimated)
Completion
Jun 9, 2028 (estimated)
Last update
Nov 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion